Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Alessandro D. Genazzani, Christian Battipaglia, Tabatha Petrillo, Nicola Piacquadio, Fedora Ambrosetti, Melania Arnesano, Elisa Semprini, Alessandra Sponzilli, Veronica Tomatis & Tommaso Simoncini. (2022) Familial diabetes predisposes PCOS patients to insulin resistance (IR), reproductive impairment and hepatic dysfunction: effects of d-chiro inositol (DCI) and alpha lipoic acid (ALA) administration on hepatic insulin extraction (HIE) index. Gynecological Endocrinology 38:8, pages 681-688.
Read now
Read now
Oliver C. Watkins, Hannah E. J. Yong, Neha Sharma & Shiao-Yng Chan. (2022) A review of the role of inositols in conditions of insulin dysregulation and in uncomplicated and pathological pregnancy. Critical Reviews in Food Science and Nutrition 62:6, pages 1626-1673.
Read now
Read now
Alessandro D. Genazzani, Alessia Prati, Federico Marchini, Tabatha Petrillo, Antonella Napolitano & Tommaso Simoncini. (2019) Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both. Gynecological Endocrinology 35:12, pages 1088-1093.
Read now
Read now
Maryam Shokrpour, Fatemeh Foroozanfard, Faraneh Afshar Ebrahimi, Zahra Vahedpoor, Esmat Aghadavod, Amir Ghaderi & Zatollah Asemi. (2019) Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial. Gynecological Endocrinology 35:5, pages 406-411.
Read now
Read now
Antoaneta Gateva, Vittorio Unfer & Zdravko Kamenov. (2018) The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review. Gynecological Endocrinology 34:7, pages 545-550.
Read now
Read now
M. Stracquadanio, L. Ciotta & M. A. Palumbo. (2018) Effects of myo-inositol, gymnemic acid, and L-methylfolate in polycystic ovary syndrome patients. Gynecological Endocrinology 34:6, pages 495-501.
Read now
Read now
E. V. Vartanyan, K. A. Tsaturova, E. A. Devyatova, A. S. Mikhaylyukova, V. A. Levin, N. L. Petuhova, A. V. Markin & E. M. Steptsova. (2017) Improvement in quality of oocytes in polycystic ovarian syndrome in programs of in vitro fertilization. Gynecological Endocrinology 33:sup1, pages 8-11.
Read now
Read now
Simona De Cicco, Valentina Immediata, Daniela Romualdi, Caterina Policola, Anna Tropea, Christian Di Florio, Valeria Tagliaferri, Elisa Scarinci, Silvia Della Casa, Antonio Lanzone & Rosanna Apa. (2017) Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action. Gynecological Endocrinology 33:9, pages 698-701.
Read now
Read now
Ewa M. Milewska, Adam Czyzyk, Blazej Meczekalski & Alessandro D. Genazzani. (2016) Inositol and human reproduction. From cellular metabolism to clinical use. Gynecological Endocrinology 32:9, pages 690-695.
Read now
Read now
Cristiana Paul, Antonio Simone Laganà, Paolo Maniglio, Onofrio Triolo & David M. Brady. (2016) Inositol’s and other nutraceuticals’ synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives. Gynecological Endocrinology 32:6, pages 431-438.
Read now
Read now
Zdravko Kamenov, Georgi Kolarov, Antoaneta Gateva, Gianfranco Carlomagno & Alessandro D. Genazzani. (2015) Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance. Gynecological Endocrinology 31:2, pages 131-135.
Read now
Read now
Alessandro D. Genazzani, Susanna Santagni, Erika Rattighieri, Elisa Chierchia, Giulia Despini, Giulia Marini, Alessia Prati & Tommaso Simoncini. (2014) Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients. Gynecological Endocrinology 30:6, pages 438-443.
Read now
Read now
Articles from other publishers (50)
Nguyen Sa Viet Le, Minh Tam Le & Thanh Ngoc Cao. (2023) Myo-inositol versus metformin effects on clinical features, endocrine and metabolic profiles in infertile women with polycystic ovary syndrome: A randomized controlled trial. Asian Pacific Journal of Reproduction 12:6, pages 256-265.
Crossref
Crossref
F. Fruzzetti, T. Fidecicchi, E. Benelli, F. Baldari & M. Tonacchera. (2023) Body mass index is a good predictor of metabolic abnormalities in polycystic ovary syndrome. Journal of Endocrinological Investigation.
Crossref
Crossref
Maryam Haghighi, Mehdi Mehdizadeh, Fatemehsadat Amjadi, Zahra Zandieh, Mohammad Najafi, Tayebe Artimani, Fatemeh Mohammadi & Rana Mehdizadeh. (2023) Effects of myo-inositol plus folic acid on ovarian morphology and oocyte quality in PCOS mouse model. Zygote, pages 1-12.
Crossref
Crossref
Alessandro D Genazzani & Andrea R Genazzani. (2023) Polycystic Ovary Syndrome as Metabolic Disease: New Insights on Insulin Resistance. European Endocrinology 19:1, pages 71.
Crossref
Crossref
Zdravko Kamenov & Mario Montanino Oliva. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols
65
72
.
Lali Pkhaladze, Vittorio Unfer & Didier Dewailly. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols
151
165
.
Umberto Capece, Simona Moffa, Ilaria Improta, Gianfranco Di Giuseppe, Enrico Celestino Nista, Chiara M. A. Cefalo, Francesca Cinti, Alfredo Pontecorvi, Antonio Gasbarrini, Andrea Giaccari & Teresa Mezza. (2022) Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features. Nutrients 15:1, pages 18.
Crossref
Crossref
Tabatha Petrillo, Elisa Semprini, Veronica Tomatis, Melania Arnesano, Fedora Ambrosetti, Christian Battipaglia, Alessandra Sponzilli, Francesco Ricciardiello, Andrea R. Genazzani & Alessandro D. Genazzani. (2022) Putative Complementary Compounds to Counteract Insulin-Resistance in PCOS Patients. Biomedicines 10:8, pages 1924.
Crossref
Crossref
Alessandro D. Genazzani, Christian Battipaglia, Elisa Semprini, Melania Arnesano, Fedora Ambrosetti, Alessandra Sponzilli, Veronica Tomatis & Tabatha Petrillo. (2022) Familial Diabetes in Obese PCOS Predisposes Individuals to Compensatory Hyperinsulinemia and Insulin Resistance (IR) Also for Reduced Hepatic Insulin Extraction (HIE). Endocrines 3:2, pages 296-302.
Crossref
Crossref
V. Soldat-Stanković, S. Popović-Pejičić, S. Stanković, A. Prtina, G. Malešević, J. Bjekić-Macut, S. Livadas, S. Ognjanović, G. Mastorakos, D. Micić & D. Macut. (2021) The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial. Journal of Endocrinological Investigation 45:3, pages 583-595.
Crossref
Crossref
O.A. Nochvinа & E.V. Slyvka. (2021) Role of inositol and its isomers in glucose metabolism. REPRODUCTIVE ENDOCRINOLOGY:62, pages 104-109.
Crossref
Crossref
Haoyu Wang, Yu Zhang, Xuhui Fang, Joanne Kwak-Kim & Li Wu. (2021) Insulin Resistance Adversely Affect IVF Outcomes in Lean Women Without PCOS. Frontiers in Endocrinology 12.
Crossref
Crossref
Selma FIRAT & Mehmet FİSUNOĞLU. (2021) Polikistik Over Sendromunda Güncel Terapötik Ajanlardan İnositol ve Alfa Lipoik Asit Takviyesi Üzerine Bir Derleme. Akdeniz Medical Journal 7:2, pages 184-196.
Crossref
Crossref
Sadia Afrin, Abdelrahman AlAshqar, Malak El Sabeh, Mariko Miyashita-Ishiwata, Lauren Reschke, Joshua T. Brennan, Amanda Fader & Mostafa A. Borahay. (2021) Diet and Nutrition in Gynecological Disorders: A Focus on Clinical Studies. Nutrients 13:6, pages 1747.
Crossref
Crossref
Małgorzata Szczuko, Iwona Szydłowska & Jolanta Nawrocka-Rutkowska. (2021) A Properly Balanced Reduction Diet and/or Supplementation Solve the Problem with the Deficiency of These Vitamins Soluble in Water in Patients with PCOS. Nutrients 13:3, pages 746.
Crossref
Crossref
Alessia Prati, Andrea R. Genazzani & Alessandro D. Genazzani. 2021. Impact of Polycystic Ovary, Metabolic Syndrome and Obesity on Women Health. Impact of Polycystic Ovary, Metabolic Syndrome and Obesity on Women Health
43
66
.
Zdravko Kamenov & Antoaneta Gateva. (2020) Inositols in PCOS. Molecules 25:23, pages 5566.
Crossref
Crossref
Lynda Guildford, Catherine Crofts & Jun Lu. (2020) Can the Molar Insulin: C-Peptide Ratio Be Used to Predict Hyperinsulinaemia?. Biomedicines 8:5, pages 108.
Crossref
Crossref
Ezhil Arasan Ramanan, Sailatha Ravi, K. R. Radha Anbu & Margaret Michael. (2020) Efficacy and Safety of Tracnil™ Administration in Patients with Dermatological Manifestations of PCOS: An Open-Label Single-Arm Study. Dermatology Research and Practice 2020, pages 1-10.
Crossref
Crossref
Heidy Cabrera-Cruz, Lorena Oróstica, Francisca Plaza-Parrochia, Ignacio Torres-Pinto, Carmen Romero & Margarita Vega. (2020) The insulin-sensitizing mechanism of myo-inositol is associated with AMPK activation and GLUT-4 expression in human endometrial cells exposed to a PCOS environment. American Journal of Physiology-Endocrinology and Metabolism 318:2, pages E237-E248.
Crossref
Crossref
H.B. SemenynaK.L. ShatylovychT.V. FartushokO.S. Komissarova & O.M. Yurchyshyn. (2020) A NEW APPROACH TO THE COMBINATION THERAPY OF POLYCYSTIC OVARY SYNDROME. World of Medicine and Biology 16:72, pages 125.
Crossref
Crossref
A. V. Vorontsova, S. A. Gasparyan, O. A. Gromova, E. M. Dzhobava, E. Yu. Kiseleva, I. N. Korotkikh, V. M. Kuleshov, T. A. Oboskalova, O. A. Pustotina, I. V. Sakhautdinova, N. V. Spiridonova, N. I. Tapil'skaya & E. B. Tkhostova. (2020) The conclusion of the Expert Council 'The product rationale based on inositol for use by patients with menstrual irregularities'. Problemy reproduktsii 26:1, pages 44.
Crossref
Crossref
І. А. Жабченко & О. Р. Сюдмак. (2019) Problems of delayed birth: the features of fertility in older reproductive age women and their correction methods. Reproductive Endocrinology 0:49, pages 43-49.
Crossref
Crossref
Federica Di Guardo, Maria Cecilia Cerana, Gisella D'urso, Fortunato Genovese & Marco Palumbo. (2019) Male PCOS equivalent and nutritional restriction: Are we stepping forward?. Medical Hypotheses 126, pages 1-3.
Crossref
Crossref
Sajadeh Pourghasem, Fatemeh Bazarganipour, Seyed Abdolvahab Taghavi & Maryam Azizi Kutenaee. (2019) The effectiveness of inositol and metformin on infertile polycystic ovary syndrome women with resistant to letrozole. Archives of Gynecology and Obstetrics 299:4, pages 1193-1199.
Crossref
Crossref
Christian Egarter. (2018) Myo-InositolMyo-inositol. Gynäkologische Endokrinologie 17:1, pages 11-15.
Crossref
Crossref
Pedro-Antonio Regidor, Adolf Eduard Schindler, Bernd Lesoine & Rene Druckman. (2018) Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature. Hormone Molecular Biology and Clinical Investigation 34:2.
Crossref
Crossref
A. D. Genazzani, K. Shefer, D. Della Casa, A. Prati, A. Napolitano, A. Manzo, G. Despini & T. Simoncini. (2017) Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients. Journal of Endocrinological Investigation 41:5, pages 583-590.
Crossref
Crossref
Giulia Mariani & José Bellver. (2018) Management Options for Infertile Women with Polycystic Ovary Syndrome. US Endocrinology 14:2, pages 67.
Crossref
Crossref
T. A. Nazarenko & K. M. Isakova. (2018) Influence of Inositol on the reproductive system of infertile patients, quality of gametes and embryos (a review). Problemy reproduktsii 24:4, pages 33.
Crossref
Crossref
Kendall C. Case, Michael Salsaa, Wenxi Yu & Miriam L. Greenberg. 2020. Lipid Signaling in Human Diseases. Lipid Signaling in Human Diseases
221
260
.
Mehri Jamilian, Pegah Farhat, Fatemeh Foroozanfard, Faraneh Afshar Ebrahimi, Esmat Aghadavod, Fereshteh Bahmani, Bita Badehnoosh, Hamidreza Jamilian & Zatollah Asemi. (2017)
Expression of Concern
: Comparison of myo‐inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: A randomized controlled clinical trial
. Clinical Endocrinology 87:2, pages 194-200.
Crossref
Crossref
Maria A. Sortino, Salvatore Salomone, Michele O. Carruba & Filippo Drago. (2017) Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols. Frontiers in Pharmacology 8.
Crossref
Crossref
Valeria Tagliaferri, Daniela Romualdi, Valentina Immediata, Simona De Cicco, Christian Di Florio, Antonio Lanzone & Maurizio Guido. (2017)
Metformin
vs
myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study
. Clinical Endocrinology 86:5, pages 725-730.
Crossref
Crossref
D. M Lukyanova & Tatyana Yu. Smolnova. (2017) THE ROLE OF SYMPATHICOTONIC REACTIVITY OF ORGANISM AND GROWTH FACTORS IN PATHOGENESIS OF SYNDROME OF POLYCYSTIC OVARY. Medical Journal of the Russian Federation 23:2, pages 96-100.
Crossref
Crossref
Antonio Simone Laganà, Paola Rossetti, Fabrizio Sapia, Benito Chiofalo, Massimo Buscema, Gaetano Valenti, Agnese Maria Chiara Rapisarda & Salvatore Giovanni Vitale. (2017) Evidence-Based and Patient-Oriented Inositol Treatment in Polycystic Ovary Syndrome: Changing the Perspective of the Disease. International Journal of Endocrinology and Metabolism 15:1.
Crossref
Crossref
E. V. Vartanyan, K. A. Tsaturova, E. A. Devyatova, A. S. Mikhaylyukova, V. A. Levin, N. L. Petuhova, A. V. Markin & E. M. Steptsova. (2017) The reserves for improvement of quality of oocytes in polycystic ovarian syndrome. Problemy reproduktsii 23:3, pages 50.
Crossref
Crossref
Alessandro D. Genazzani. (2016) Inositol as putative integrative treatment for PCOS. Reproductive BioMedicine Online 33:6, pages 770-780.
Crossref
Crossref
Samer El Hayek, Lynn Bitar, Layal H. Hamdar, Fadi G. Mirza & Georges Daoud. (2016) Poly Cystic Ovarian Syndrome: An Updated Overview. Frontiers in Physiology 7.
Crossref
Crossref
Marco Noventa, Amerigo Vitagliano, Michela Quaranta, Shara Borgato, Baydaa Abdulrahim & Salvatore Gizzo. (2016) Preventive and Therapeutic Role of Dietary Inositol Supplementation in Periconceptional Period and During Pregnancy: A Summary of Evidences and Future Applications. Reproductive Sciences 23:3, pages 278-288.
Crossref
Crossref
Pedro-Antonio Regidor & Adolf Eduard Schindler. (2016) Myoinositol as a Safe and Alternative Approach in the Treatment of Infertile PCOS Women: A German Observational Study. International Journal of Endocrinology 2016, pages 1-5.
Crossref
Crossref
Giovanna Muscogiuri, Stefano Palomba, Antonio Simone Laganà & Francesco Orio. (2016) Inositols in the Treatment of Insulin-Mediated Diseases. International Journal of Endocrinology 2016, pages 1-6.
Crossref
Crossref
Amerigo Vitagliano, Michela Quaranta, Marco Noventa & Salvatore Gizzo. (2015) “Empiric” inositol supplementation in normal-weight non insulin resistant women with polycystic ovarian disease: from the absence of benefit to the potential adverse effects. Archives of Gynecology and Obstetrics 291:5, pages 955-957.
Crossref
Crossref
Antonio Simone Laganà, Luisa Barbaro & Alfonsa Pizzo. (2014) Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with d-Chiro-Inositol. Archives of Gynecology and Obstetrics 291:5, pages 1181-1186.
Crossref
Crossref
Nazia Siddiqui, Vijay Singh, Milind M. Deshmukh & Ramanathan Gurunath. (2015) Structures, stability and hydrogen bonding in inositol conformers. Physical Chemistry Chemical Physics 17:28, pages 18514-18523.
Crossref
Crossref
Mariagrazia Stracquadanio & Lilliana CiottaMariagrazia Stracquadanio & Lilliana Ciotta. 2015. Metabolic Aspects of PCOS. Metabolic Aspects of PCOS
89
137
.
Alessandro D. Genazzani, Susanna Santagni, Erika Rattighieri, Elisa Chierchia, Giulia Despini, Alessia Prati & Federica Ricchieri. 2015. Frontiers in Gynecological Endocrinology. Frontiers in Gynecological Endocrinology
11
23
.
Alessandro D. Genazzani, Susanna Santagni, Federica Ricchieri, Annalisa Campedelli, Erika Rattighieri, Elisa Chierchia, Giulia Marini, Giulia Despini, Alessia Prati & Tommaso Simoncini. (2014) Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome. Journal of Obstetrics and Gynaecology Research 40:5, pages 1353-1360.
Crossref
Crossref
Susanna Santagni, Erika Rattighieri, Elisa Chierchia, Giulia Despini & Alessandro D Genazzani. 2014. Frontiers in Gynecological Endocrinology. Frontiers in Gynecological Endocrinology
69
76
.
Alessandro D. Genazzani, Alessia Prati, Giulia Despini, Giulia Marini & Federica Ricchieri. 2014. Frontiers in Gynecological Endocrinology. Frontiers in Gynecological Endocrinology
59
67
.